ADMA Biologics Inc
NASDAQ:ADMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
C
|
CECONOMY AG
F:CEC
|
DE |
|
P
|
PepsiCo Inc
SIX:PEP
|
US |
|
Austin Engineering Ltd
ASX:ANG
|
AU |
|
S
|
Sixt SE
XMUN:SIX2
|
DE |
|
C
|
China Aerospace International Holdings Ltd
SWB:CIOC
|
HK |
|
C
|
China Southern Airlines Co Ltd
XMUN:ZNHH
|
CN |
|
M
|
Mitsubishi Estate Co Ltd
OTC:MITEF
|
JP |
|
S
|
Savills PLC
F:1YZ
|
UK |
Intrinsic Value
Is ADMA undervalued or overvalued?
See the intrinsic value estimate for ADMA Biologics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ADMA looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ADMA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What ADMA Biologics Does
ADMA Biologics makes plasma-derived medicines, especially immune globulin therapies used to help patients with weakened immune systems fight infections. It also runs plasma collection centers, which supply the human plasma used to make those drugs. The company sells its products mainly to hospitals, specialty pharmacies, and other healthcare providers that treat patients with serious immune disorders.
- Headquarters
- United States of America US
- Employees
- 647
- IPO date
- Oct 17, 2013
ADMA Biologics has a wide economic moat
ADMA Biologics Inc possesses a wide economic moat, providing strong and durable advantages that protect its market position and profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
ADMA Biologics Inc
Earnings Waterfall
ADMA Biologics Inc
The intrinsic value for ADMA Biologics Inc (ADMA) under the Base Case is hidden USD.
Compared with the current market price of 11.1495 USD, the stock appears hidden.